linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
PG Electroplast Ltd.
 
Source DateBoard Meeting DateDetails
07 Nov 202513 Nov 2025 Quarterly Results
01 Aug 202508 Aug 2025 Quarterly Results
05 May 202512 May 2025 Final Dividend & Audited Results
29 Jan 202506 Feb 2025 Quarterly Results
04 Nov 202411 Nov 2024 Quarterly Results
17 Oct 202419 Oct 2024 Inter alia, to consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s) and / or combination(s) thereof as may be considered appropriate, by way of issuance of any instruments or securities, through private placement, preferential issue, rights issue, qualified institutions placement or such other methods or combinations thereof as may be decided by the Board, subject to such approvals as may be required, and to transact other businesses with the permission of the Chairperson.
18 Jul 202424 Jul 2024 Quarterly Results
03 May 202422 May 2024 Stock Split & Final Dividend & Audited Results
01 Feb 202413 Feb 2024 Quarterly Results
27 Oct 202306 Nov 2023 Quarterly Results
29 Aug 202301 Sep 2023 Inter alia, to consider the issue price of Equity Shares to be issued pursuant to the QIP, including any discount on the floor price calculated in accordance with the SEBI ICDR Regulations and as permitted by the SEBI ICDR Regulations and approved by the shareholders pursuant to a resolution dated September 29, 2022.
28 Jul 202304 Aug 2023 Quarterly Results
18 May 202326 May 2023 Audited Results
27 Jan 202304 Feb 2023 Quarterly Results
07 Nov 202214 Nov 2022 Quarterly Results
04 Aug 202212 Aug 2022 Quarterly Results & Inter alia, To review the fund raising limit approved vide Board meeting held on May 28, 2022 by way of equity issuance through Qualified Institutional Placement ("QIP").
20 May 202228 May 2022 Audited Results Inter alia, to consider: b) The proposal for raising funds by way of issue of equity or equity convertible instrument either by way of Rights Issue, Preferential Issue, QIP issue or any other mode as may be decided by the Board. c) Any other matter brought before the Board, with the kind consent of the chair. This is for your information and record.
04 Feb 202214 Feb 2022 Quarterly Results
08 Nov 202113 Nov 2021 Quarterly Results
05 Aug 202114 Aug 2021 Quarterly Results
Page 1 of 4
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.